Fighting antibiotic resistance the right way.

Parx Plastics has finished it verification tests on different grades of acrylics (PMMA) and adds them to the portfolio of antimicrobial concentrates. These thermoplastics are used for the production of sheets that are lightweight and shatter-resistant which are ideal to be formed into shapes for hospital beds.

This new material brings the Parx technology into area’s where antimicrobial resistance is a topic of discussion.  Antimicrobial resistance (AMR) refers to the ability of micro-organisms to withstand antimicrobial treatments. The overuse or misuse of antibiotics has been linked to the emergence and spread of micro-organisms which are resistant to them, rendering treatment ineffective and posing a serious risk to public health.

The technology developed by Parx Plastics stands out in this discussion as the technology is derived from how nature is dealing with bacteria. Over four years of dedicated biomimetic research has been invested to create a 100% safe and biocompatible technology to inhibit the growth of bacteria on the surface of plastic with the use of a biomimetic approach in the design and engineering of the materials. The discoveries and inventions done during this research are truly unique and groundbreaking. A team of 11 professors, scientists and researchers with decades of experience in the field of Nano- and biotechnologies and skilled in chemical, chemical-physical and microbial analyses have been working together with a renown European university for chemistry. The result is a worldwide-patented innovation for plastics with a highly effective antibacterial/antimicrobial effectiveness rate of up tot 99%. A technique copied from nature and most of all safe. 


The method to incorporate this highly effective antimicrobial property into plastics is not making use of any harmful substances, it is not touching the original characteristics of the material, and it is not migrating. So there are no substances leaching from the materials. The plastic is incorporated with a biocompatible solution to make the material and the surface of the object produced more resistant to the attack by microbes and bacteria. The development and proliferation of bacteria on the surface of the object are slowed down and the microbes and bacteria count is being strongly reduced up to 99% measured according to ISO22196. 

The antimicrobial property is merely due to the (changed) mechanical/physical properties of the surface and not due to migration. Bacteria cannot develop and proliferate on the surface of the material and there are no toxins or biocides involved to which antimicrobial resistance can be build up. A truly safe solution, copied from nature.


Parx Plastics with its headquarters in Rotterdam (The Netherlands) and a laboratory in Bologna (Italy) brings to the market an innovative biocompatible technique to incorporate an up to 99% effective antibacterial/antimicrobial property into plastics. In 2014 Parx Plastics was endorsed by the European Commission, by Vice-President Neelie Kroes, as being one of the top-3 tech startups of Europe. Learn more at:

For more information, please contact:
t: +31 (0)10-340 00 95

This prerelease is available in:  English, Dutch, Italian, Portuguese and Chinese.
For the related files and high resolution images please see the Dropbox folder here

Parx PlasticsParx Plastics